Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pravin R Jadhav

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Pharmacology|October 1, 2010
Antiviral Information Management System (AIMS): a prototype for operational innovation in drug developmentPravin R Jadhav, Lauren Neal, Jeff Florian, et al.
Journal of Clinical Pharmacology|June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendationsPravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Gastroenterology|March 9, 2013
Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapiesJianmeng Chen, Jeffry Florian, Wendy Carter, et al.
Journal of Clinical Pharmacology|December 21, 2007
Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory reviewChristine E Garnett, Nhi Beasley, V Atul Bhattaram, et al.
Hepatology (Baltimore, Md.)|May 22, 2012
Boceprevir dosing for late responders and null responders: the role of bridging data between treatment-naïve and -experienced subjectsJeffry Florian, Pravin R Jadhav, Shashi Amur, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjectsJiang Liu, Pravin R Jadhav, Shashi Amur, et al.
Journal of Clinical Pharmacology|January 18, 2008
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006Yaning Wang, A Venkatesh Bhattaram, Pravin R Jadhav, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Pharmacology|October 1, 2010
Antiviral Information Management System (AIMS): a prototype for operational innovation in drug developmentPravin R Jadhav, Lauren Neal, Jeff Florian, et al.
Journal of Clinical Pharmacology|June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendationsPravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Gastroenterology|March 9, 2013
Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapiesJianmeng Chen, Jeffry Florian, Wendy Carter, et al.
Journal of Clinical Pharmacology|December 21, 2007
Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory reviewChristine E Garnett, Nhi Beasley, V Atul Bhattaram, et al.
Hepatology (Baltimore, Md.)|May 22, 2012
Boceprevir dosing for late responders and null responders: the role of bridging data between treatment-naïve and -experienced subjectsJeffry Florian, Pravin R Jadhav, Shashi Amur, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjectsJiang Liu, Pravin R Jadhav, Shashi Amur, et al.
Journal of Clinical Pharmacology|January 18, 2008
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006Yaning Wang, A Venkatesh Bhattaram, Pravin R Jadhav, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Pageof 2